1. Home
  2. VST vs NTRA Comparison

VST vs NTRA Comparison

Compare VST & NTRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vistra Corp.

VST

Vistra Corp.

N/A

Current Price

$139.39

Market Cap

47.0B

Sector

Utilities

ML Signal

N/A

Logo Natera Inc.

NTRA

Natera Inc.

N/A

Current Price

$410.26

Market Cap

47.4B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
VST
NTRA
Founded
1882
2003
Country
United States
United States
Employees
6390
N/A
Industry
Electric Utilities: Central
Medical Specialities
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
47.0B
47.4B
IPO Year
2016
2015

Fundamental Metrics

Financial Performance
Metric
VST
NTRA
Price
$139.39
$410.26
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
20
24
Target Price
$212.79
★ $352.80
AVG Volume (30 Days)
★ 3.7M
1.2M
Earning Date
11-06-2026
11-05-2026
Dividend Yield
★ 0.67%
N/A
EPS Growth
N/A
★ 0.65
EPS
★ 3.64
N/A
Revenue
★ $17,738,000,000.00
$210,939,000.00
Revenue This Year
$26.65
$26.17
Revenue Next Year
$6.44
$20.40
P/E Ratio
$38.21
★ N/A
Revenue Growth
★ 2.98
N/A
52 Week Low
$132.66
$160.59
52 Week High
$217.10
$421.64

Technical Indicators

Market Signals
Indicator
VST
NTRA
Relative Strength Index (RSI) 48.68 83.00
Support Level $135.54 $187.64
Resistance Level $168.74 N/A
Average True Range (ATR) 3.57 13.91
MACD -0.04 3.74
Stochastic Oscillator 52.13 88.66

Price Performance

Historical Comparison
VST
NTRA

About VST Vistra Corp.

Vistra Corp. is one of the largest power producers and retail energy providers in the US. It owns 44 gigawatts of generation capacity, including natural gas (27 GW), nuclear (6.5 GW), coal (8.7 GW), and solar and battery storage (1.3 GW). The Cogentrix acquisition will add 5.5 GW of gas generation. Vistra's retail electricity business serves 5 million customers in 20 states, including almost a third of all Texas electricity consumers. Vistra emerged from the Energy Future Holdings bankruptcy as a stand-alone entity in 2016.

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

Share on Social Networks: